A top Wall Street analyst shares why Moderna's stock is poised to tumble 20% — even if the biotech's coronavirus shot works (MRNA)

6:47am PDT - July 23rd, 2020    moderna stock - Business Insider

• A top Wall Street analyst expects Moderna's coronavirus vaccine to succeed, but says the biotech's stock could still fall by about 20% over the next year. 
• SVB Leerink analyst Mani Foroohar started covering Moderna on Thursday with a $65 pri…